The monkey pox treatment global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Monkey Pox Treatment Market, 2024The monkey pox treatment global market report 2024
Market Size –
The monkey pox treatment market size has grown rapidly in recent years. It will grow from $0.08 billion in 2023 to $0.09 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to outbreaks in endemic regions, zoonotic transmission awareness, smallpox eradication legacy, public health initiatives, emergence of human cases.
The monkey pox treatment market size is expected to see rapid growth in the next few years. It will grow to $0.15 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to globalization and travel, government funding and support, biotech and pharmaceutical investment, public health surveillance, and regulatory approvals. Major trends in the forecast period include antiviral drug development, use of smallpox vaccines, monoclonal antibodies, combination therapies, and long-term immunity research.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report
Scope Of Monkey Pox Treatment MarketThe Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Monkey Pox Treatment Market Overview
Market Drivers –
The growing prevalence of zoonotic infections is expected to propel the growth of the monkeypox (mpox) treatment market in the foreseeable future. A zoonotic infection is transmitted from animals to humans, typically through direct contact with contaminated environments or vectors. The increased interaction between humans and animals heightens the risk of zoonotic infections. Additionally, climate change exacerbates this risk by extending the ranges of disease vectors and introducing pathogens to new regions. Treatments for monkeypox are essential in managing zoonotic mpox by targeting the virus and alleviating symptoms in both humans and potentially infected animals. For instance, in August 2024, the UK Health Security Agency, a UK-based government agency, reported 3,732 confirmed mpox cases in the UK, with an increase of 21 cases from 2023, which had recorded 3,753 cases. Therefore, the increasing prevalence of zoonotic infections is significantly driving the growth of the monkeypox treatment market through 2023, into 2024, and projected to continue expanding by 2028.
Market Trends –
Major companies operating in the monkeypox treatment market focus on remote monitoring and teletherapy solutions such as virtual care to enhance accessibility, streamline patient management, and improve overall treatment outcomes. Virtual care for monkeypox treatment provides remote medical consultations, symptom evaluation, and management strategies to individuals at risk or infected, facilitating access to care while reducing the need for in-person visits. For instance, in August 2022, Folx Health, a US-based healthcare company, introduced Monkeypox Care, virtual primary care services for individuals at risk of or affected by monkeypox. It employs a comprehensive strategy that includes education, counseling, symptom evaluation, and referrals. The initiative is designed to reach individuals in care deserts—areas with limited access to healthcare, ensuring that quality information and referrals are accessible to all, regardless of location.
The monkey pox treatment market covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines, Therapeutics
2) By Dosage Forms: Solid, Liquid, Semi Solid
3) By Route Of Administration: Oral, Topical, Parenteral
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Get an inside scoop of the monkey pox treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp
Regional Insights –
North America was the largest region in the monkey pox treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies in the market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc
Table of Contents
1. Executive Summary
2. Monkey Pox Treatment Market Characteristics
3. Monkey Pox Treatment Market Trends And Strategies
4. Monkey Pox Treatment Market – Macro Economic Scenario
5. Global Monkey Pox Treatment Market Size and Growth
…
32. Global Monkey Pox Treatment Market Competitive Benchmarking
33. Global Monkey Pox Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Monkey Pox Treatment Market
35. Monkey Pox Treatment Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
